Literature DB >> 29524077

Evaluation of mitral regurgitation by an integrated 2D echocardiographic approach in patients undergoing transcatheter aortic valve replacement.

R Jansen1, A M Wind1, M J Cramer1, F Nijhoff1, P Agostoni1,2, F Z Ramjankhan3, W J Suyker3, P R Stella1, S A J Chamuleau4.   

Abstract

The purpose of this study was to evaluate mitral regurgitation (MR) severity in patients undergoing transcatheter aortic valve replacement (TAVR) by standardized assessment of two-dimensional (2D) transthoracic echocardiography (TTE) and 1-year echocardiographic and clinical outcomes. Pre- and post-procedural TTE's of patients undergoing TAVR between 2008 and 2014 were analyzed. MR was graded according to current guidelines with a systematic and integrated approach. Longitudinal echocardiographic and clinical results were analyzed. Regression analysis was performed for change in MR grade at follow-up, using pre-determined variables and confounders. Pre- and post-procedural TTE were available in 213 subjects. Significant MR was seen in 22% at baseline and 15% at follow-up; MR grade ≥ 3 in < 10%. Severity did not change in 61%, and decreased in 20% of the patients. Overall, the prevalence of MR grades pre- and post TAVR was not significantly different, nor influenced by MR etiology or TAVR prosthesis type. However, higher MR grades and pacemaker absence at baseline, were independently correlated to more improvement of MR after TAVR. Regarding clinical outcomes, NYHA class improved in two-thirds of the patients, irrespective of the baseline MR grade. Overall survival was not significantly different amongst MR grades post-TAVR. MR grading using an systematic 2D echocardiographic approach in patients undergoing TAVR is feasible in clinical practice. Our data revealed a relatively frequent prevalence of significant MR (although grade ≥ 3 was scarce), overall no change in the MR grade at 1 year follow-up, improvement of functional NYHA class, and no significant differences in long-term survival amongst the post-TAVR MR grades.

Entities:  

Keywords:  2D transthoracic echocardiography; Mitral regurgitation; Scoring index; Transcatheter aortic valve replacement

Mesh:

Year:  2018        PMID: 29524077     DOI: 10.1007/s10554-018-1328-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  46 in total

Review 1.  Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice.

Authors:  M Enriquez-Sarano; C Tribouilloy
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Transcatheter aortic implantation of the Edwards-SAPIEN bioprosthesis: insights on early benefit of TAVI on mitral regurgitation.

Authors:  Mariam Samim; Pieter R Stella; Pierfrancesco Agostoni; Jolanda Kluin; Faiez Ramjankhan; Gertjan Sieswerda; Riccardo Budde; Marijke van der Linden; Morsal Samim; Marieke Hillaert; Lex van Herwerden; Pieter A M Doevendans; Eric van Belle
Journal:  Int J Cardiol       Date:  2011-08-12       Impact factor: 4.164

Review 4.  Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era.

Authors:  Luis Nombela-Franco; Henrique Barbosa Ribeiro; Marina Urena; Ricardo Allende; Ignacio Amat-Santos; Robert DeLarochellière; Eric Dumont; Daniel Doyle; Hugo DeLarochellière; Jerôme Laflamme; Louis Laflamme; Eulogio García; Carlos Macaya; Pilar Jiménez-Quevedo; Mélanie Côté; Sebastien Bergeron; Jonathan Beaudoin; Philippe Pibarot; Josep Rodés-Cabau
Journal:  J Am Coll Cardiol       Date:  2014-03-26       Impact factor: 24.094

5.  Natural history and predictors of outcome in patients with concomitant functional mitral regurgitation at the time of aortic valve replacement.

Authors:  Marc Ruel; Varun Kapila; Joel Price; Alexander Kulik; Ian G Burwash; Thierry G Mesana
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

6.  Natural history of coexistent mitral regurgitation after aortic valve replacement.

Authors:  Sarah A Schubert; Leora T Yarboro; Sushma Madala; Karnika Ayunipudi; Irving L Kron; John A Kern; Gorav Ailawadi; George J Stukenborg; Ravi K Ghanta
Journal:  J Thorac Cardiovasc Surg       Date:  2015-12-12       Impact factor: 5.209

7.  Effects of valve replacement for aortic stenosis on mitral regurgitation.

Authors:  Philippe Unger; Danièle Plein; Guy Van Camp; Bernard Cosyns; Agnès Pasquet; Valérie Henrard; Didier de Cannière; Christian Melot; Luc A Piérard; Patrizio Lancellotti
Journal:  Am J Cardiol       Date:  2008-09-11       Impact factor: 2.778

8.  Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.

Authors:  Andrea Hutter; Sabine Bleiziffer; Valerie Richter; Anke Opitz; Ina Hettich; Domenico Mazzitelli; Hendrik Ruge; Ruediger Lange
Journal:  Ann Thorac Surg       Date:  2012-10-11       Impact factor: 4.330

9.  Changes in mitral regurgitation after replacement of the stenotic aortic valve.

Authors:  Emily C Waisbren; Louis-Mathieu Stevens; Edwin G Avery; Michael H Picard; Gus J Vlahakes; Arvind K Agnihotri
Journal:  Ann Thorac Surg       Date:  2008-07       Impact factor: 4.330

Review 10.  Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging.

Authors:  Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Bogdan A Popescu; Thor Edvardsen; Luc A Pierard; Luigi Badano; Jose L Zamorano
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-06-03       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.